Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated with JAK Inhibitors and TNF Inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study

被引：0
|
作者：
Cho, Yongtai [1 ]
Yoon, Dongwon [2 ]
Khosrow-Khavar, Farzin [3 ]
Song, Minkyo [4 ]
Kim, Ju Hwan [1 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea
[2] NIA, NIH, Bethesda, MD USA
[3] Rutgers State Univ, New Brunswick, NJ USA
[4] NIA, NIH, Lab Epidemiol & Populat Sci, Bethesda, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
73
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis and ulcerative colitis: A nationwide cohort study
    Cho, Yongtai
    Yoon, Dongwon
    Khosrow-Khavar, Farzin
    Song, Minkyo
    Kang, Eun Ha
    Kim, Ju Hwan
    Shin, Ju-Young
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (04) : 366 - 381
  • [2] Acute Cardiovascular Events Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a Nationwide Cohort Study: RELATION Study
    gottenberg, jacques-eric
    Mammar, Nadir
    Kessouri, Meriem
    Rudant, Jeremie
    Assi, nada
    grenier, Benjamin
    kirchgesner, julien
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2816 - 2819
  • [3] ACUTE CARDIOVASCULAR EVENTS RISK IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR TNF INHIBITORS, A NATIONWIDE COHORT STUDY: RELATION STUDY
    Gottenberg, J. E.
    Kessouri, M.
    Rudant, J.
    Assi, N.
    Grenier, B.
    Kirchgesner, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 402 - 402
  • [4] THE COMPARISON OF MALIGNANCY RISK BETWEEN JAK INHIBITORS AND TNF INHIBITORS IN MULTICENTER COHORT STUDY
    Uchida, T.
    Iwamoto, N.
    Fukui, S.
    Morimoto, S.
    Aramaki, T.
    Shomura, F.
    Aratake, K.
    Eguchi, K.
    Ueki, Y.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 717 - 718
  • [5] PREVALENCE OF RISK FACTORS FOR CARDIOVASCULAR EVENTS, MALIGNANCY OR THROMBOEMBOLIC EVENTS IN RHEUMATOID ARTHRITIS UNDER JAK INHIBITORS IN A REAL-LIFE MONOCENTRIC COHORT
    Giovannini, I.
    Agarinis, R.
    Cacioppo, S.
    Sacco, S.
    De Marchi, G.
    Di Poi, E.
    Zabotti, A.
    Quartuccio, L.
    De Vita, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1439 - 1440
  • [6] Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study
    Hoisnard, Lea
    Vegas, Laura Pina
    Dray-Spira, Rosemay
    Weill, Alain
    Zureik, Mahmoud
    Sbidian, Emilie
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (02) : 182 - 188
  • [7] Risk of Major Adverse Cardiovascular and Venous Thromboembolism Events in Patients with Rheumatoid Arthritis Exposed to JAK Inhibitors versus Adalimumab: A Nationwide Cohort Study
    Hoisnard, Lea
    Vegas, Laura Pina
    Dray-Spira, Rosemary
    Weill, Alain
    Zureik, Mahmoud
    Sbidian, Emilie
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1442 - 1442
  • [8] THERAPY WITH JAK INHIBITORS AND THE RISK OF CARDIOVASCULAR EVENTS IN A DUTCH RHEUMATOID ARTHRITIS POPULATION
    Popa, C.
    Opdam, M.
    Den Broeder, N.
    Wientjes, M.
    Den Broeder, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 145 - 146
  • [9] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Se Rim Choi
    Anna Shin
    You-Jung Ha
    Yun Jong Lee
    Eun Bong Lee
    Eun Ha Kang
    Arthritis Research & Therapy, 25
  • [10] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
12345